OC000459 Dose Finding Study in Hay Fever Sufferers.

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2008

Conditions
Allergic Rhinitis
Interventions
DRUG

OC000459

"Tablets twice daily for 8 days~Dose level 1"

DRUG

OC000459

"Tablets twice daily for 8 days~Dose level 2"

DRUG

OC000459

"Tablets twice daily for 8 days~Dose level 3"

DRUG

OC000459

"Tablets twice daily for 8 days~Dose level 4"

DRUG

Placebo

"Tablets twice daily for 8 days~Dose level 5"

Trial Locations (1)

1150 VIENNA

Allergie Zentrum Wien West, Vienna Challenge Chamber, Vienna

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Oxagen Ltd

INDUSTRY